News Daily News GLP-1 Receptor Agonists Come With Broad Array of Benefits, Risks Todd Neale January 21, 2024
News Daily News Testosterone Doesn’t Cause CV Events in High-Risk Men With Hypogonadism Caitlin E. Cox June 16, 2023
News Daily News OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer L.A. McKeown December 16, 2022
News Daily News Early Aspirin Tied to Less In-Hospital Mortality in Moderate COVID-19 Todd Neale March 25, 2022
News Daily News More Evidence Links Breast Arterial Calcification and CVD Risk L.A. McKeown March 15, 2022
News Daily News Shorter Anticoagulation an Option for Young Patients With Provoked VTE Todd Neale January 11, 2022
News Daily News MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission Todd Neale December 29, 2021
News Daily News HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients Yael L. Maxwell October 12, 2021
News Daily News Thrombotic Events Frequent Among COVID-19 Patients in ICUs Michael O'Riordan October 27, 2020
News Daily News Rivaroxaban May Yet Protect After a Hospital Stay: MARINER Caitlin E. Cox June 25, 2020
News Daily News Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus Michael O'Riordan April 29, 2020
News Daily News How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions Michael O'Riordan April 22, 2020
News Daily News Trial Affirms Aspirin Is Safe to Continue Before Coronary Artery Surgery Todd Neale February 25, 2016
News Daily News Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene L.A. McKeown July 13, 2015
News Daily News After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist L.A. McKeown July 13, 2015